1. Home
  2. LQDT vs JANX Comparison

LQDT vs JANX Comparison

Compare LQDT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$38.73

Market Cap

1.0B

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$15.79

Market Cap

984.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
JANX
Founded
1999
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
984.3M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
LQDT
JANX
Price
$38.73
$15.79
Analyst Decision
Buy
Buy
Analyst Count
1
13
Target Price
$40.00
$47.00
AVG Volume (30 Days)
191.1K
918.4K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
N/A
EPS
0.46
N/A
Revenue
$476,669,000.00
$10,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$81.65
N/A
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$12.12
52 Week High
$41.28
$35.34

Technical Indicators

Market Signals
Indicator
LQDT
JANX
Relative Strength Index (RSI) 51.86 54.62
Support Level $36.36 $13.13
Resistance Level $38.63 $16.68
Average True Range (ATR) 1.15 0.62
MACD -0.23 -0.11
Stochastic Oscillator 45.12 39.94

Price Performance

Historical Comparison
LQDT
JANX

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: